These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25451127)

  • 1. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.
    London ED; Kohno M; Morales AM; Ballard ME
    Brain Res; 2015 Dec; 1628(Pt A):174-85. PubMed ID: 25451127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study.
    Dean AC; Kohno M; Hellemann G; London ED
    Brain Behav; 2014; 4(6):867-76. PubMed ID: 25365801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiological mechanisms of physical exercise in methamphetamine addiction.
    Morais APD; Pita IR; Fontes-Ribeiro CA; Pereira FC
    CNS Neurosci Ther; 2018 Feb; 24(2):85-97. PubMed ID: 29266758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
    Chang L; Alicata D; Ernst T; Volkow N
    Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 6. Bouncing back: Brain rehabilitation amid opioid and stimulant epidemics.
    Stewart JL; May AC; Paulus MP
    Neuroimage Clin; 2019; 24():102068. PubMed ID: 31795056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural abnormalities in the brains of human subjects who use methamphetamine.
    Thompson PM; Hayashi KM; Simon SL; Geaga JA; Hong MS; Sui Y; Lee JY; Toga AW; Ling W; London ED
    J Neurosci; 2004 Jun; 24(26):6028-36. PubMed ID: 15229250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse of amphetamines and structural abnormalities in the brain.
    Berman S; O'Neill J; Fears S; Bartzokis G; London ED
    Ann N Y Acad Sci; 2008 Oct; 1141():195-220. PubMed ID: 18991959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study.
    Salo R; Nordahl TE; Buonocore MH; Natsuaki Y; Waters C; Moore CD; Galloway GP; Leamon MH
    Biol Psychiatry; 2009 Jan; 65(2):122-8. PubMed ID: 18814867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.
    Groman SM; Morales AM; Lee B; London ED; Jentsch JD
    Psychopharmacology (Berl); 2013 Oct; 229(3):527-38. PubMed ID: 23748383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction time variability and related brain activity in methamphetamine psychosis.
    Fassbender C; Lesh TA; Ursu S; Salo R
    Biol Psychiatry; 2015 Mar; 77(5):465-74. PubMed ID: 25444164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
    London ED
    Adv Pharmacol; 2016; 76():67-84. PubMed ID: 27288074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive decision-making processes of casual methamphetamine users.
    Droutman V; Xue F; Barkley-Levenson E; Lam HY; Bechara A; Smith B; Lu ZL; Xue G; Miller LC; Read SJ
    Neuroimage Clin; 2019; 21():101643. PubMed ID: 30612937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.
    Dean AC; Kohno M; Morales AM; Ghahremani DG; London ED
    Drug Alcohol Depend; 2015 Jun; 151():84-91. PubMed ID: 25840750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis.
    Hall MG; Alhassoon OM; Stern MJ; Wollman SC; Kimmel CL; Perez-Figueroa A; Radua J
    Am J Drug Alcohol Abuse; 2015; 41(4):290-9. PubMed ID: 26125488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence.
    Kohno M; Morales AM; Ghahremani DG; Hellemann G; London ED
    JAMA Psychiatry; 2014 Jul; 71(7):812-20. PubMed ID: 24850532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.
    Morales AM; Lee B; Hellemann G; O'Neill J; London ED
    Drug Alcohol Depend; 2012 Oct; 125(3):230-8. PubMed ID: 22445480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine users show greater than normal age-related cortical gray matter loss.
    Nakama H; Chang L; Fein G; Shimotsu R; Jiang CS; Ernst T
    Addiction; 2011 Aug; 106(8):1474-83. PubMed ID: 21438934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticolimbic dysregulation and chronic methamphetamine abuse.
    Baicy K; London ED
    Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study.
    Vuletic D; Dupont P; Robertson F; Warwick J; Zeevaart JR; Stein DJ
    Neuroimage Clin; 2018; 20():1157-1162. PubMed ID: 30380522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.